Episode Details
Back to Episodes
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
Season 1
Published 1 year, 9 months ago
Description
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.
CME information and select publications here.